Home Belviq Lawsuits

Belviq Lawsuits

Belviq lawsuits are being filed against Eisai Inc. because of the drug’s link to cancer. The lawsuits began after the U.S. Food and Drug Administration asked Eisai to pull it off the market. A five-year study of Belviq users convinced the FDA that the drug posed an increased cancer risk.

This is an active lawsuit
See if you can file

See If You Qualify for a Belviq Lawsuit

If you or your loved one were diagnosed with cancer after taking Belviq, you may be entitled to compensation. Get a free case review today.

We value your privacy. By clicking REVIEW MY CASE, you agree to our privacy policy and disclaimer. After submitting, you will be contacted by one or more of Drugwatch's trusted legal partners (including autodialed and prerecorded calls or text/SMS messages). Msg. and data rates apply. Your consent to text messaging is not required for a case review and you may opt out of text messages at any time by texting STOP. This is legal advertising.
Last Modified: January 24, 2023
Fact Checked

Editors carefully fact-check all Drugwatch content for accuracy and quality.

Drugwatch has a stringent fact-checking process. It starts with our strict sourcing guidelines.

We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.

Why Trust DrugWatch?

Drugwatch.com has been empowering patients for more than a decade

Drugwatch.com has provided reliable, trusted information about medications, medical devices and general health since 2008. We’ve also connected thousands of people injured by drugs and medical devices with top-ranked national law firms to take action against negligent corporations.

Our team includes experienced medical writers, award-winning journalists, researchers and certified medical and legal experts. Drugwatch.com is HONCode (Health On the Net Foundation) certified. This means the high-quality information we provide comes from credible sources, such as peer-reviewed medical journals and expert interviews.

The information on Drugwatch.com has been medically and legally reviewed by more than 30 expert contributors, including doctors, pharmacists, lawyers, patient advocates and other health care professionals. Our writers are members of professional associations, including American Medical Writers Association, American Bar Association, The Alliance of Professional Health Advocates and International Society for Medical Publication Professionals.

About Drugwatch.com

  • Assisting patients and their families since 2008.
  • Helped more than 12,000 people find legal help.
  • A+ rating from the Better Business Bureau.
  • 5-star reviewed medical and legal information site.
Learn More About Us


"Drugwatch opened my eyes to the realities of big pharmacy. Having a family member with major depression and anxiety, I was looking for information on her medications. I found information that was very helpful, that her psychiatrist never told her."
Marianne Zahren Patient’s Family Member
  • Google Business Rating
  • BBB A+ Rating Logo

Belviq, or lorcaserin, was a weight loss drug approved by the FDA in 2012 to treat obesity. It was also prescribed to overweight people who had serious weight-related health conditions such as diabetes and high blood pressure.

It was available by prescription in its original form and in an extended release version, Belviq XR. Both are the subject of Belviq lawsuits.

Arena Pharmaceuticals manufactures Belviq at its facility in Switzerland. Eisai Inc. marketed and distributed Belviq in the United States. Both companies are named in lawsuits.

Cancer Link Led People to File Belviq Lawsuits

On Feb. 13, 2020, the FDA requested that Eisai Inc. voluntarily withdraw the drug over the potential cancer link. The agency based its decision on results from a five-year study of Belviq users that the company had conducted to make sure there were no serious cardiovascular risks associated with the drug.

“We are taking this action because we believe that the risks of lorcaserin outweigh its benefits based on our completed review of results from a randomized clinical trial assessing safety,” the FDA announcement read.

When the FDA approved Belviq, it required Eisai to conduct a long-term study into the drug’s cardiovascular effects. The study involved 12,000 people, some taking Belviq and others taking a placebo.

Data from the trial showed that 7.7 percent of the people taking Belviq developed cancer, compared to 7.1 percent taking the placebo.

Belviq users who developed any one of three different types of cancer began filing lawsuits shortly after the FDA announcement.

Types of cancer named in Belviq lawsuits:

The company complied with the FDA’s request, but it issued a statement saying that its interpretation of data from the study differed from the FDA’s.

“The company’s assessment is that Belviq and Belviq XR continue to have a positive benefit-risk profile in the patient population for which they are indicated,” the statement read.

The statement added that Eisai respected the FDA’s decision and was working with the agency to remove its drug from the market.

Were you diagnosed with pancreatic cancer, colorectal cancer or lung cancer after taking Belviq?

Status of Belviq Lawsuits

Plaintiffs’ lawyers have asked the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate cases from across the country into multidistrict litigation (MDL) in the Eastern District of Louisiana, according to a motion filed on April 12, 2021.

“It is estimated that hundreds of individuals (if not numbers in the low thousands) developed cancer as a direct and proximate result of using and ingesting Defendants’ Belviq. Many of these injured individuals have filed or will be filing lawsuits against Defendants,” lawyers said in court documents.

In August 2021, a judge ruled Belviq cases would proceed without being consolidated in an MDL.

Belviq Settlements

In May, 2022, U.S. District Judge Anne Conway agreed to a request to stay all proceedings while plaintiffs and defendants try to negotiate a global settlement. The stay was supposed to end in August 2022.

As of November 2022, some cases have settled for undisclosed amounts and negotiations are ongoing.


Who Can File a Belviq Lawsuit?

People who developed lung, pancreatic or colorectal cancer after taking Belviq for a total of six months may be eligible to file a lawsuit. It does not have to be six months in a row. They should have taken Belviq within seven years of being diagnosed with cancer.

The cancers must have originated in the lung, pancreas or colon; it cannot have spread to them from other organs.

Those who lost a loved one to cancer after they took Belviq should talk to a lawyer within a year and a half of his or her death.

People considering a Belviq lawsuit should have details of their personal cancer history with them when they talk to an attorney about filing a case.

Questions Attorneys May Ask

What type of cancer did you develop after taking Belviq?
People who had been taking Belviq and later went on to file lawsuits were generally diagnosed with pancreatic, colorectal or lung cancer as their primary cancer.

How long had you been taking Belviq before you were diagnosed with cancer?
Individuals had typically been taking Belviq for at least six months prior to their cancer diagnosis.

Had you previously been diagnosed with cancer?
Your attorney will want to know if you had previously been diagnosed with pancreatic, colorectal or lung cancer prior to taking Belviq or Belviq XR as this could put you more at risk of developing these cancers again.

When did you last use Belviq?
Individuals filing lawsuits typically had taken Belviq or Belviq XR within seven years of their cancer diagnosis.

Can you provide a copy of your medical records?
Your Belviq lawyer will want to see copies of your medical records to review any information related to your cancer diagnosis.

What type of cancer treatment are you undergoing?
Be prepared to discuss the cancer treatment options your medical provider had recommended for you and which one you selected. Your attorney will want to know if it’s been effective.

Are you older than 18 years of age?
Belviq is indicated only for use in adults. For this reason, anyone under the age of 18 who took Belviq will likely not be eligible to file a lawsuit.

When did your loved one pass away from cancer?
If you’re seeking to file a lawsuit on behalf of a family member who passed away from cancer caused by Belviq, keep in mind that it’s important to act quickly. People filing lawsuits generally contact an attorney within a year and half of their loved one’s passing.

Please seek the advice of a medical professional before making health care decisions.
Related Pages